Try our beta test site
2 studies found for:    "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Lymphoma, Follicular"
Show Display Options
Rank Status Study
1 Recruiting A Study of Obinutuzumab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Polatuzumab Vedotin;   Drug: Venetoclax
2 Recruiting Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma;   Lymphoproliferative Disorder
Interventions: Other: biologic sample preservation procedure;   Other: informational intervention

Study has passed its completion date and status has not been verified in more than two years.